After the FDA reaffirmed the end of Zepbound’s two-year shortage, drug companies have announced shortages for 32 presentations of seven medications.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
After the FDA reaffirmed the end of Zepbound’s two-year shortage, drug companies have announced shortages for 32 presentations of seven medications.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis